Wang Weimin, Qian Jie, Zhu Minfang, Wang Yinghua, Pan Yan
Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Department of Emergency Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Ann Transl Med. 2022 Jan;10(2):99. doi: 10.21037/atm-22-42.
Utilization rate of donor lungs in China is constrained by the inefficiency of conventional cold preservation (COLD) in lung transplantation. We assessed the performance of normothermic ex vivo lung perfusion (EVLP) in lung donors following cardiac death (DCD) with fresh EVLP perfusate.
A total of 24 adult Sprague-Dawley (SD) rats were randomized into three groups (EVLP, COLD, and control groups) with 8 rats each. Fresh EVLP perfusate was prepared for lung perfusion. The pH, electrolyte concentration, perfusate penetration pressure during irrigation, physiological function, integrity of barrier function, pathological changes, and expressions of inflammation-related cytokines of donor lungs were examined.
The pH, electrolyte concentration, osmotic pressure of the perfusate were kept stable for 4 hours after EVLP was administered. Pulmonary arterial pressure (PAP), pulmonary venous pressure (PVP), pulmonary venous oxygenation index (PaO/FiO), and end carbon dioxide partial pressure (PCO) in the EVLP group were all within acceptable limits. After 4 hours, the oxygenation index was significantly higher in the EVLP group compared with that of the COLD group (P=0.0032). The EVLP group had a decreased wet/dry weight ratio (P=0.0155) and Evans blue dye content (P=0.0075) compared to that of the COLD group. Pathological examination showed more obvious lung damage in the COLD group than in the EVLP group. However, there was no difference in protein expression of high mobility group box 1 (HMGB1) and toll-like receptor 4 (TLR4) between the EVLP group and the COLD group.
Fresh lung perfusate could be used for EVLP to protect and repair donor lungs. Normothermic EVLP performed better than conventional cold preservation. EVLP might be powerful for lung quality maintenance and may have potential for anti-inflammation.
中国肺移植中供肺的利用率受到肺移植传统冷保存(COLD)效率低下的限制。我们评估了使用新鲜体外肺灌注(EVLP)灌注液对心脏死亡(DCD)后肺供体进行常温体外肺灌注(EVLP)的效果。
将24只成年Sprague-Dawley(SD)大鼠随机分为三组(EVLP组、COLD组和对照组),每组8只。制备新鲜的EVLP灌注液用于肺灌注。检测供肺的pH值、电解质浓度、灌注时的灌注液渗透压力、生理功能、屏障功能完整性、病理变化以及炎症相关细胞因子的表达。
EVLP灌注后,灌注液的pH值、电解质浓度和渗透压在4小时内保持稳定。EVLP组的肺动脉压(PAP)、肺静脉压(PVP)、肺静脉氧合指数(PaO/FiO)和终末二氧化碳分压(PCO)均在可接受范围内。4小时后,EVLP组的氧合指数显著高于COLD组(P = 0.0032)。与COLD组相比,EVLP组的湿/干重比(P = 0.0155)和伊文思蓝染料含量(P = 0.0075)降低。病理检查显示COLD组的肺损伤比EVLP组更明显。然而,EVLP组和COLD组之间高迁移率族蛋白B1(HMGB1)和Toll样受体4(TLR4)的蛋白表达没有差异。
新鲜肺灌注液可用于EVLP以保护和修复供肺。常温EVLP的效果优于传统冷保存。EVLP在维持肺质量方面可能很有效,并且可能具有抗炎潜力。